Rationale for the Use of Combination Injectable Therapy in Patients With Type 2 Diabetes Who Have High A1C (≥9%) and/or Long Duration (>8 Years): Executive Summary.
作者信息
Fonseca Vivian A, Sood Minisha, Galindo Rodolfo J
机构信息
Tulane University Health Sciences Center, New Orleans, LA.